LBX Pharmacy Chain Joint Stock Company (603883.SS)
CNY 18.62
(-2.31%)
CNY 18.62
(-2.31%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 929.02 Million CNY | 18.35% |
| 2022 | 784.96 Million CNY | 17.29% |
| 2021 | 669.23 Million CNY | 7.75% |
| 2020 | 621.09 Million CNY | 22.09% |
| 2019 | 508.71 Million CNY | 16.94% |
| 2018 | 435.03 Million CNY | 17.32% |
| 2017 | 370.8 Million CNY | 24.89% |
| 2016 | 296.89 Million CNY | 23.45% |
| 2015 | 240.5 Million CNY | 18.84% |
| 2014 | 202.38 Million CNY | 25.92% |
| 2013 | 160.72 Million CNY | 28.54% |
| 2012 | 125.03 Million CNY | 26.35% |
| 2011 | 98.96 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 181.44 Million CNY | -43.52% |
| 2024 Q1 | 321.25 Million CNY | 51.21% |
| 2024 Q3 | 127.44 Million CNY | -29.76% |
| 2023 Q2 | 221.91 Million CNY | -23.83% |
| 2023 FY | 929.02 Million CNY | 18.35% |
| 2023 Q4 | 212.46 Million CNY | 4.5% |
| 2023 Q3 | 203.31 Million CNY | -8.38% |
| 2023 Q1 | 291.33 Million CNY | 10.87% |
| 2022 Q1 | 241.79 Million CNY | 76.99% |
| 2022 FY | 784.96 Million CNY | 17.29% |
| 2022 Q4 | 262.77 Million CNY | 71.61% |
| 2022 Q3 | 153.12 Million CNY | -28.68% |
| 2022 Q2 | 214.7 Million CNY | -11.2% |
| 2021 Q4 | 136.61 Million CNY | 7.77% |
| 2021 Q2 | 178.31 Million CNY | -21.63% |
| 2021 Q1 | 227.54 Million CNY | 70.12% |
| 2021 Q3 | 126.76 Million CNY | -28.91% |
| 2021 FY | 669.23 Million CNY | 7.75% |
| 2020 Q3 | 151.32 Million CNY | 8.17% |
| 2020 Q1 | 196.11 Million CNY | 71.37% |
| 2020 Q2 | 139.89 Million CNY | -28.67% |
| 2020 FY | 621.09 Million CNY | 22.09% |
| 2020 Q4 | 133.75 Million CNY | -11.61% |
| 2019 Q3 | 124.15 Million CNY | 12.17% |
| 2019 Q2 | 110.68 Million CNY | -30.57% |
| 2019 Q1 | 159.43 Million CNY | 44.45% |
| 2019 FY | 508.71 Million CNY | 16.94% |
| 2019 Q4 | 114.43 Million CNY | -7.83% |
| 2018 Q3 | 103.39 Million CNY | 13.97% |
| 2018 FY | 435.03 Million CNY | 17.32% |
| 2018 Q4 | 110.37 Million CNY | 6.75% |
| 2018 Q1 | 130.54 Million CNY | 35.39% |
| 2018 Q2 | 90.72 Million CNY | -30.51% |
| 2017 Q1 | 113.33 Million CNY | 27.85% |
| 2017 FY | 370.8 Million CNY | 24.89% |
| 2017 Q4 | 96.42 Million CNY | 16.08% |
| 2017 Q3 | 83.06 Million CNY | 6.51% |
| 2017 Q2 | 77.98 Million CNY | -31.19% |
| 2016 Q2 | 65.77 Million CNY | -16.82% |
| 2016 Q4 | 88.64 Million CNY | 39.79% |
| 2016 FY | 296.89 Million CNY | 23.45% |
| 2016 Q1 | 79.06 Million CNY | 3.44% |
| 2016 Q3 | 63.41 Million CNY | -3.59% |
| 2015 Q4 | 76.43 Million CNY | 74.93% |
| 2015 Q2 | 54.74 Million CNY | -16.58% |
| 2015 Q1 | 65.62 Million CNY | 6.64% |
| 2015 Q3 | 43.69 Million CNY | -20.18% |
| 2015 FY | 240.5 Million CNY | 18.84% |
| 2014 Q2 | 49.21 Million CNY | -11.65% |
| 2014 Q4 | 61.53 Million CNY | 71.29% |
| 2014 Q3 | 35.92 Million CNY | -27.0% |
| 2014 FY | 202.38 Million CNY | 25.92% |
| 2014 Q1 | 55.7 Million CNY | 0.0% |
| 2013 FY | 160.72 Million CNY | 28.54% |
| 2012 FY | 125.03 Million CNY | 26.35% |
| 2011 FY | 98.96 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Shanghai No.1 Pharmacy Co., Ltd. | 89.27 Million CNY | -940.628% |
| Jointown Pharmaceutical Group Co., Ltd | 2.17 Billion CNY | 57.267% |
| Yifeng Pharmacy Chain Co., Ltd. | 1.41 Billion CNY | 34.204% |
| Yunnan Jianzhijia Health-Chain Co., Ltd. | 414.41 Million CNY | -124.179% |